Home/Filings/4/0001127602-21-015364
4//SEC Filing

Piacquad David 4

Accession 0001127602-21-015364

CIK 0000318154other

Filed

May 3, 8:00 PM ET

Accepted

May 4, 7:38 PM ET

Size

10.8 KB

Accession

0001127602-21-015364

Insider Transaction Report

Form 4
Period: 2021-04-30
Piacquad David
SVP, Business Development
Transactions
  • Award

    Nqso (Right to Buy)

    2021-04-30+6,1596,159 total
    Exercise: $239.64From: 2023-04-30Exp: 2031-04-30Common Stock (6,159 underlying)
  • Tax Payment

    Common Stock

    2021-05-03$239.64/sh220$52,72144,787 total
  • Tax Payment

    Common Stock

    2021-05-01$239.64/sh139$33,31045,007 total
  • Award

    Common Stock

    2021-04-30+70945,146 total
Footnotes (4)
  • [F1]The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/30/2023, 4/30/2024 and 4/30/2025, respectively.
  • [F2]These shares include the following RSUs granted under the Company's equity plans: 326 RSUs which will vest on 4/27/2022; 1,133 RSUs which will vest in installments of 558 on 5/3/2022 and 575 on 5/3/2023; 1,269 RSUs which vest in installments of 418 on 5/5/2022, 419 on 5/5/2023 and 432 on 5/5/2024; and 709 RSUs which vest in installments of 233 on 4/30/2023, 234 on 4/30/2024 and 242 on 4/30/2025. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
  • [F3]These shares include 134 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount.
  • [F4]These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 4/30/2023, 4/30/2024 and 4/30/2025, respectively.

Issuer

AMGEN INC

CIK 0000318154

Entity typeother

Related Parties

1
  • filerCIK 0001602343

Filing Metadata

Form type
4
Filed
May 3, 8:00 PM ET
Accepted
May 4, 7:38 PM ET
Size
10.8 KB